Drug Shortage Report for DELATESTRYL
Report ID | 134792 |
Drug Identification Number | 00029246 |
Brand name | DELATESTRYL |
Common or Proper name | DELATESTRYL |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | TESTOSTERONE ENANTHATE |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | n/a |
ATC code | G03BA |
ATC description | ANDROGENS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2021-05-31 |
Estimated end date | 2021-09-07 |
Actual end date | 2021-09-10 |
Shortage status | Resolved |
Updated date | 2021-09-13 |
Company comments | API availability |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v28 | 2021-09-13 | French | Compare |
v27 | 2021-09-13 | English | Compare |
v26 | 2021-08-12 | French | Compare |
v25 | 2021-08-12 | English | Compare |
v24 | 2021-06-18 | French | Compare |
v23 | 2021-06-18 | English | Compare |
v22 | 2021-06-14 | French | Compare |
v21 | 2021-06-14 | English | Compare |
v20 | 2021-06-02 | French | Compare |
v19 | 2021-06-02 | English | Compare |
v18 | 2021-06-02 | English | Compare |
v17 | 2021-05-29 | English | Compare |
v16 | 2021-05-26 | French | Compare |
v15 | 2021-05-26 | English | Compare |
v14 | 2021-05-22 | English | Compare |
v13 | 2021-05-19 | French | Compare |
v12 | 2021-05-19 | English | Compare |
v11 | 2021-05-15 | English | Compare |
v10 | 2021-05-05 | French | Compare |
v9 | 2021-05-05 | English | Compare |